Virtual screening

From WikiMD's Food, Medicine & Wellness Encyclopedia

FlowChart

Virtual screening (VS) is a computational technique used in drug discovery to search large libraries of small molecules in order to identify those structures which are most likely to bind to a drug target, typically a protein receptor or enzyme. Virtual screening has become an integral part of the drug discovery process as it allows for the rapid and cost-effective identification of potential drug candidates before they are synthesized and tested in laboratory experiments.

Overview[edit | edit source]

Virtual screening involves the use of computer simulations to estimate the affinity of a large number of compounds for a given biological target. The process can be divided into two main types: structure-based virtual screening (SBVS) and ligand-based virtual screening (LBVS).

Structure-Based Virtual Screening[edit | edit source]

SBVS, also known as docking, relies on the knowledge of the three-dimensional structure of the biological target obtained through methods such as X-ray crystallography or NMR spectroscopy. Compounds are computationally "docked" into the binding site of the target protein, and their potential binding affinity is evaluated using scoring functions.

Ligand-Based Virtual Screening[edit | edit source]

LBVS does not require knowledge of the target structure but instead uses information from known active compounds to identify new ligands. Techniques used in LBVS include quantitative structure-activity relationship (QSAR) modeling, pharmacophore modeling, and similarity searching.

Applications[edit | edit source]

Virtual screening is widely used in the pharmaceutical industry to enhance the efficiency of the drug discovery process. It is applied in the identification of lead compounds in the early stages of drug development, optimization of lead compounds, and investigation of the mechanism of action of drugs.

Challenges and Future Directions[edit | edit source]

Despite its advantages, virtual screening faces several challenges, including the accuracy of scoring functions in predicting binding affinity, the handling of protein flexibility, and the need for large computational resources. Ongoing research in the field aims to address these issues through the development of more sophisticated algorithms, the integration of artificial intelligence and machine learning techniques, and the use of cloud computing to improve the scalability of virtual screening campaigns.


This article is a stub.

Help WikiMD grow by registering to expand it.
Editing is available only to registered and verified users.
About WikiMD: A comprehensive, free health & wellness encyclopedia.

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD